Cited 0 times in
Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.